Patient preferences for HIV/AIDS therapy - a discrete choice experiment

Axel Mühlbacher1,2, Matthias Stoll3, Jörg Mahlich4,5, Matthias Nübling1
1Gesellschaft für empirische Beratung, Empirical Consulting, Denzlingen, Germany
2Hochschule Neubrandenburg, Neubrandenburg, Germany
3Medizinische Hochschule Hannover, Hannover, Germany
4Janssen Cilag, Neuss, Germany
5University of Vienna, Vienna, Austria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pichenot M, Deuffic-Burban S, Cuzin L: Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials. HIV Med 2012, 13: 148–155.

Thompson MA, Aberg JA, Hoy JF: Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012, 308: 387–402. 10.1001/jama.2012.7961

Case KK, Ghys PD, Gouws E: Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ 2012, 90: 831–838A. 10.2471/BLT.12.102574

Centers for Disease Control and Prevention (CDC): Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981, 30: 250–252.

Global Report: UNAIDS Report on the global AIDS epidemic (PDF). , downloaded on January, 27th 2013 http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf

World Health Organization (WHO): Adherence to long term therapies – evidence for action. , 2003, downloaded on May 3rd 2012 http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf

Grierson J, Koelmeyer RL, Smith A: Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med 2011, 12: 562–569. 10.1111/j.1468-1293.2011.00928.x

DHHS panel: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (PDF). Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection; 2012:1–240. , downloaded on January 27th 2013 http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

Nübling M, Andersen H, Mühlbacher AC: Entwicklung eines Verfahrens zur Berechnung der körperlichen und psychischen Summenskalen auf Basis der SOEP - Version des SF 12 (Algorithmus). Data Documentation 16. Berlin: Deutsches Institut für Wirtschaftsforschung (DIW); 2006. , downloaded on May 3rd 2012 http://www.diw.de/documents/publikationen/73/diw_01.c.56544.de/diw_sp0006.pdf

Train K: Discrete choice methods with simulation. Cambridge: Univ. Press; 2003.

Heidbrink M: Reliabilität und Validität von Verfahren der Präferenzmessung. Ein meta-analytischer Vergleich verschiedener Verfahren der Conjoint-Analyse. Universität Münster, Dissertation; 2006. , downloaded on May 3rd 2012 https://miami.uni-muenster.de/servlets/DerivateServlet/Derivate-3827/diss_heidbrink.pdf

Bridges J, Onukwugha E, Johnson F: Patient preference methods–a patient centered evaluation paradigm. ISPOR Connections 2007, 13: 4–7.

Lancaster KJ: A new approach to consumer theory. Journal of Political Economy 1966, 74: 132–157. 10.1086/259131

McFadden D: Conditional logit analysis of qualitative choice behavior. In Frontiers in Economics. Edited by: Zarembka P. New York: Academic Press; 1974.

Ben-Akiva ME, Lerman SR: Discrete choice analysis: theory and application to travel demand. Cambridge: MIT Press; 1985.

Mühlbacher AC, Juhnke C, Bethge S: Experts’ judgment on patient-centered coordinated care. Value Health 2010,13(7):A337.

Telser H: Nutzenmessung im Gesundheitswesen: Die Methode der Discrete-Choice-Experimente. Hamburg: Kovac; 2002.

Street DJ, Burgess L: The construction of optimal stated choice experiments, theory and methods. New Jersey: Wiley; 2007.

Bradley M: User’s Manual for SPEED Version 2.1 Stated preference experiment editor and designer. Hague Consulting Group: Hague; 1991.

Louviere JJ, Hensher DA, Swait JD: Stated choice methods: analysis and application. Cambridge: Univ. Press; 2000.

Hensher DA, Rose JM, Greene WH: Applied choice analysis: a primer. Cambridge: Univ. Press; 2005.

Bridges JF, Kinter ET, Kidane L: Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982–2007. Patient 2008, 1: 273–282. 10.2165/1312067-200801040-00009

Ryan M, Gerard K, Amaya-Amaya M: Using discrete choice experiments to value health and health care. Dordrecht: Springer; 2008.

Lancsar E, Louviere J, Flynn T: Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med 2007, 64: 1738–1753. 10.1016/j.socscimed.2006.12.007

Jansen K, Brockmeyer NH, Hahn M: Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German competence network for HIV/AIDS. Eur J Med Res 2009, 14: 415–425.

KompNet HIV/AIDS: Kompetenznetz HIV/AIDS. Aktuelle Daten. 2012. , downloaded on May 3rd 2012 http://www.kompetenznetz-hiv.de/projekte/1180.htm

Stone VE, Jordan J, Tolson J: Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr 2004, 36: 808–816. 10.1097/00126334-200407010-00007

Beusterien KM, Dziekan K, Flood E: Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment. Value Health 2005, 8: 453–461. 10.1111/j.1524-4733.2005.00036.x

Bätzing-Feigenbaum J, Kollan C, Kühne A: Cohort profile: the German ClinSurv HIV project – a multicentre open clinical cohort study supplementing national HIV surveillance. HIV Med 2011, 12: 269–278. 10.1111/j.1468-1293.2010.00879.x

Robert-Koch-Institut (RKI): HIV-Infektionen und AIDS-Erkrankungen in Deutschland. Epidemiologisches Bulletin 2011, 21: 172–198.